advertisement
Abstract #106840 Published in IGR 23-3
Evidence-Based Consensus Guidelines Series for MicroPulse Transscleral Laser Therapy - Surgical Technique, Post-Operative Care, Expected Outcomes and Retreatment/Enhancements
Grippo TM; Töteberg-Harms M; Giovingo M; Francis BA; de Crom RRMPC; Jerkins B; Brubaker JW; An J; Radcliffe N; Noecker RClinical Ophthalmology 2023; 17: 71-83
PURPOSE: To provide expert consensus and evidence-based current guidelines on treatment technique, postoperative care, expected outcomes and retreatment for MicroPulse Transscleral Laser Treatment (TLT). METHODS: A comprehensive search of PubMed led to the identification and analysis of 61 studies on MicroPulse TLT. To provide guidance in areas where there was not enough available literature, a three-round Delphi method was conducted involving 10 international experts in MicroPulse TLT. RESULTS: The response rate was 70% in the first round, 70% in the second round, and 80% in the third round of the Delphi method. Once all responses were aggregated, a live meeting was held with 90% attendance, and consensus was achieved on each of the findings detailed in this manuscript. CONCLUSION: Used within appropriate treatment parameters, with proper technique and patient selection, MicroPulse TLT is a safe and effective treatment for many types and severities of glaucoma. MicroPulse TLT represents a useful addition to the glaucoma armamentarium.
Grippo Glaucoma and Cataract Center, Buenos Aires, Argentina.
Full article